The Choroideremia Research Foundation (CRF) announces the first cycle of 2026 research grants, with applications due by December 31, 2025.
SPRINGFIELD, MA, UNITED STATES, December 4, 2025 /EINPresswire.com/ -- The Choroideremia Research Foundation (CRF), dedicated to finding treatments and a cure for choroideremia (CHM), announces that the deadline for the first cycle of 2026 research grant applications is December 31, 2025. Since its founding, CRF has awarded over $6 million to more than 100 research projects, advancing understanding and treatment options for this rare genetic condition.
CRF’s mission is clear: to accelerate the development of effective treatments and ultimately
a cure for choroideremia. Achieving this goal relies on supporting research that:Provides essential resources and knowledge for the field, such as model systems, insights into genetic mechanisms, and annotated patient specimens.
- Opens innovative pathways for diagnosis and drug discovery.
- Supports promising projects less likely to receive traditional funding, including:
- Seed funding for hypothesis-generating studies
- High-quality proposals from young investigators
- Foundational projects with long-term but high-impact potential
All grant applications will be reviewed by CRF’s Science Advisory Board twice a year, with the next review cycle at the end of January.
Researchers interested in applying should submit their proposals via email to:
Kathi Wagner, Executive Director: kathiwagner@curechm.org
Jess Thompson, MD, Science Advisory Board and Research Committee Chair: jessthompson@curechm.org
Mike McConnell, PhD, Chief Scientific Officer: cso@curechm.org
“CRF is proud to support research that has the potential to transform the lives of those affected by choroideremia,” said Kathi Wagner, CRF Executive Director. “By funding innovative and foundational projects, we continue to move closer to a future where choroideremia can be effectively treated or cured.”
For more information on grant opportunities and application guidelines, visit curechm.org/research/#_funding
No comments:
Post a Comment